Blind Spot: ¹⁸F-FDG PET Fails to Reveal Atherosclerosis Aggravated by Cancer Immunotherapy

JACC CardioOncol. 2020 Oct 6;2(4):611-613. doi: 10.1016/j.jaccao.2020.08.008. eCollection 2020 Nov.

Authors

Klaus Ley^{1

2}, Payel Roy¹

Affiliations

¹ Laboratory of Inflammation Biology, La Jolla Institute for Immunology, La Jolla, California, USA.
² Department of Bioengineering, University of California-San Diego, La Jolla, California, USA.

No abstract available

Keywords: FDG-PET; atherosclerosis; autoimmunity; immune checkpoint inhibitor.

Publication types

Editorial